Rybelsus (semaglutide) 3 mg is the initial, temporary starting dose of a daily oral medication used to improve blood sugar control in adults with type 2 diabetes, along with diet and exercise. It acts as a GLP-1 receptor agonist, reducing A1C and potentially causing weight loss. Common side effects include nausea, diarrhea, vomiting, and stomach pain.
